ACORDA THERAPEUTICS INC

ARDSLEY, NY How do I update this listing?

Acorda Therapeutics is based out of Ardsley. Acorda Therapeutics, Inc., a biopharmaceutical company, engages in the identification, development, and commercialization of various therapies for the improvement of neurological functions in people with multiple sclerosis (MS), spinal cord injury, and other disorders of the central nervous system in the United States. It markets Zanaflex Capsules and Zanaflex tablets, a short-acting drug indicated for the management of spasticity. The company's lead product candidate is Fampridine-SR, which is in a Phase III clinical trial for the improvement of walking ability in people with multiple sclerosis. Its preclinical programs comprise remyelination programs that include two distinct therapeutic approaches to stimulate repair of the damaged myelin sheath in MS, Glial Growth Factor 2, or GGF-2, and remyelinating antibodies; and Chondroitinase Program that develops second generation approaches to overcoming the proteoglycan matrix. Acorda Therapeutics sells its products through internal specialty sales force and contract pharmaceutical telesales organizations.Whalewisdom has at least 2 13D filings, and 317 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Create Email Alert

Contact Info

acorda therapeutics inc
420 SAW MILL RIVER ROAD
ARDSLEY NY    10502

Business Phone: 914-347-4300
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Biotie Therapies Corp Unsponsored ADR (BITI) HEALTH CARE 1,154,150,273 29,777,077,043.40 1 13D 2018-04-18

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Elevate your investments